HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 136 filers reported holding HORIZON PHARMA PLC in Q4 2014. The put-call ratio across all filers is 0.21 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $2,584,000 | +53.3% | 132,216 | +53.6% | 0.05% | +21.4% |
Q3 2018 | $1,686,000 | -13.7% | 86,091 | -37.4% | 0.04% | -33.3% |
Q1 2018 | $1,954,000 | +38.6% | 137,592 | +42.5% | 0.06% | +75.0% |
Q4 2017 | $1,410,000 | +332.5% | 96,558 | +275.9% | 0.04% | +350.0% |
Q3 2017 | $326,000 | +9.8% | 25,688 | +27.8% | 0.01% | -11.1% |
Q1 2017 | $297,000 | -82.4% | 20,100 | -80.7% | 0.01% | -79.1% |
Q4 2016 | $1,684,000 | +87.3% | 104,075 | +109.8% | 0.04% | +104.8% |
Q3 2016 | $899,000 | -25.6% | 49,605 | -32.0% | 0.02% | -32.3% |
Q1 2016 | $1,209,000 | +14.8% | 72,983 | +50.3% | 0.03% | +3.3% |
Q4 2015 | $1,053,000 | +340.6% | 48,570 | +303.5% | 0.03% | +275.0% |
Q3 2015 | $239,000 | -95.0% | 12,038 | -91.2% | 0.01% | -94.2% |
Q2 2015 | $4,773,000 | +303.8% | 137,400 | +201.9% | 0.14% | +265.8% |
Q1 2015 | $1,182,000 | -66.6% | 45,508 | -83.4% | 0.04% | -69.1% |
Q4 2014 | $3,539,000 | -2.2% | 274,577 | -6.9% | 0.12% | -6.1% |
Q3 2014 | $3,620,000 | – | 294,814 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,018,021 | $44,063,000 | 7.20% |
SCOPIA CAPITAL MANAGEMENT LP | 16,370,364 | $239,007,000 | 4.29% |
JW Asset Management, LLC | 270,775 | $3,953,000 | 4.21% |
Avoro Capital Advisors LLC | 4,436,183 | $64,768,000 | 4.20% |
Rhenman & Partners Asset Management AB | 1,954,912 | $28,542,000 | 3.86% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,341,894 | $92,592,000 | 3.64% |
Paulson & Co. | 7,870,700 | $114,912,000 | 2.24% |
Proxima Capital Management, LLC | 260,000 | $3,796,000 | 2.20% |
KOPP INVESTMENT ADVISORS LLC | 105,126 | $1,535,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 1,000,000 | $14,600,000 | 1.46% |